Literature DB >> 2194711

Correlation of orbital computed tomography and antibodies in patients with hyperthyroid Graves' disease.

T C Chang1, K M Huang, T J Chang, S L Lin.   

Abstract

The purpose of this study was to elucidate the incidence of orbital changes in computed tomography, and the relationships of orbital changes with eye-muscle antibody (EMAb), thyrotrophin-binding inhibitor immunoglobulin (TBII), antithyroglobulin antibody (TgAb) and anti-thyroid microsomal antibody (MsAb), in 55 consecutive patients with hyperthyroid Graves' disease. EMAb was demonstrated by an immunoperoxidase technique. The results showed that the prevalence of orbital fat increase, extraocular muscle enlargement, lacrimal gland enlargement and optic nerve swelling were 54.5, 41.8, 21.8 and 16.5% respectively. There were 32.7% of patients without any orbital changes. The patients with extraocular muscle enlargement, lacrimal gland enlargement and optic nerve swelling had higher titres of EMAb than the patients without these orbital changes. The patients with lacrimal gland enlargement had a lower TBII index than those without. There was no difference in TgAb or MsAb between the patients with extraocular muscle enlargement, lacrimal gland enlargement, optic nerve swelling or orbital fat increase and those patients without these orbital changes. The patients with extraocular muscle enlargement, optic nerve swelling and orbital fat increase had a higher degree of exophthalmos than the patients without these orbital changes. EMAb was negatively correlated with TBII. However, there was no correlation between EMAb and TgAb or MsAb. The degree of exophthalmos was positively correlated with EMAb and negatively correlated with age. There was no correlation between exophthalmos and TBII, TgAb or MsAb. In conclusion, although the pathogenesis of orbital changes and hyperthyroidism is different, a close link between these two entities is suggested by the high incidence of orbital changes in hyperthyroid Graves' disease.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2194711     DOI: 10.1111/j.1365-2265.1990.tb00897.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  11 in total

1.  Usefulness of TSH receptor antibodies as biomarkers for Graves' ophthalmopathy: a systematic review.

Authors:  S Seo; M Sánchez Robledo
Journal:  J Endocrinol Invest       Date:  2018-09-07       Impact factor: 4.256

2.  Inflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathy.

Authors:  Danping Huang; Nuo Xu; Yiyue Song; Peijuan Wang; Huasheng Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-11-30       Impact factor: 3.117

3.  Ocular surface inflammation, and nerve growth factor level in tears in active thyroid-associated ophthalmopathy.

Authors:  Jin Sook Yoon; Soo Hyun Choi; Joon H Lee; Sung Jun Lee; Sang Yeul Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-10-21       Impact factor: 3.117

4.  Increased generation of fibrocytes in thyroid-associated ophthalmopathy.

Authors:  Raymond S Douglas; Nikoo F Afifiyan; Catherine J Hwang; Kelvin Chong; Uzma Haider; Patrick Richards; Andrew G Gianoukakis; Terry J Smith
Journal:  J Clin Endocrinol Metab       Date:  2009-11-06       Impact factor: 5.958

5.  The levels of 12 cytokines and growth factors in tears: hyperthyreosis vs euthyreosis.

Authors:  Jelena Juri Mandić; Ana Kozmar; Sanja Kusačić-Kuna; Anamarija Jazbec; Krešimir Mandić; Danijela Mrazovac; Nenad Vukojević
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-01-14       Impact factor: 3.117

6.  Tear Proteins Calcium binding protein A4 (S100A4) and Prolactin Induced Protein (PIP) are Potential Biomarkers for Thyroid Eye Disease.

Authors:  Chiaw-Ling Chng; Lay Leng Seah; Morgan Yang; Sunny Yu Shen; Siew Kwan Koh; Yan Gao; Lu Deng; Louis Tong; Roger Wilmer Beuerman; Lei Zhou
Journal:  Sci Rep       Date:  2018-11-16       Impact factor: 4.379

7.  Ocular Surface Changes in Patients with Thyroid Eye Disease: An Observational Clinical Study.

Authors:  Ibrahim Y Allam; Sihem Lazreg; Mohamed Shafik Shaheen; Mohamed Fahmy Doheim; Mai A Mohammed
Journal:  Clin Ophthalmol       Date:  2021-06-15

8.  Patient acceptability of tear collection in the primary healthcare setting.

Authors:  Joanne Hui Min Quah; Louis Tong; Sylvaine Barbier
Journal:  Optom Vis Sci       Date:  2014-04       Impact factor: 1.973

9.  Diagnosis and stage of Graves' ophthalmopathy: Efficacy of quantitative measurements of the lacrimal gland based on 3-T magnetic resonance imaging.

Authors:  Hao Hu; Xiao-Quan Xu; Fei-Yun Wu; Huan-Huan Chen; Guo-Yi Su; Jie Shen; Xun-Ning Hong; Hai-Bin Shi
Journal:  Exp Ther Med       Date:  2016-05-25       Impact factor: 2.447

10.  The function and morphology of Meibomian glands in patients with thyroid eye disease: a preliminary study.

Authors:  Chia-Yu Wang; Ren-Wen Ho; Po-Chiung Fang; Hun-Ju Yu; Chun-Chih Chien; Chang-Chun Hsiao; Ming-Tse Kuo
Journal:  BMC Ophthalmol       Date:  2018-04-12       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.